Encompass Health CAO surrenders shares for taxes

Encompass Health Corp Chief Accounting Officer Andrew L. Price reported two tax-related share dispositions under an equity award.

Rhea-AI Filing Summary

Encompass Health Corp Chief Accounting Officer Andrew L. Price reported two tax-related share dispositions under an equity award. On February 19, 2026, 3,692 shares of Encompass Health common stock were surrendered at $107.15 per share, and on February 20, 2026, a further 228 shares were surrendered at $106.55 per share.

According to the footnote, these shares were withheld or surrendered to pay tax withholding obligations triggered by the vesting of related restricted stock, rather than sold as discretionary open-market trades. After these transactions, Price directly owned 75,405 shares of Encompass Health common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 3,920 shares

Exercise Price or Tax Liability 2 txns

Insider Price Andrew L

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	228	$106.55	$24K
Exercise Price or Tax Liability	Encompass Health Common Stock	3,692	$107.15	$396K

Holdings After Transaction: Encompass Health Common Stock — 75,405 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

What did Encompass Health (EHC) insider Andrew L. Price report on this Form 4?

Andrew L. Price, Chief Accounting Officer of Encompass Health, reported two tax-related dispositions of common stock. Shares were surrendered to cover withholding taxes arising from restricted stock vesting, rather than from open-market selling, and he continued to hold a substantial direct share position afterward.

How many Encompass Health (EHC) shares were surrendered for tax withholding?

A total of 3,920 Encompass Health common shares were surrendered for tax withholding. This included 3,692 shares on February 19, 2026, at $107.15 per share and 228 shares on February 20, 2026, at $106.55 per share, all tied to restricted stock vesting.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F indicates shares were used to pay an exercise price or tax liability. In this case, Encompass Health common stock was withheld or surrendered specifically to satisfy the insider’s tax withholding obligations related to the vesting of restricted stock awards.

Did the Encompass Health (EHC) CAO still hold shares after the tax-withholding dispositions?

Yes. After the reported tax-withholding dispositions, Andrew L. Price directly owned 75,405 shares of Encompass Health common stock. The reported Form 4 shows his remaining direct ownership position following the restricted stock vesting and associated share surrenders.

Were the Encompass Health (EHC) insider transactions open-market sales?

No. The Form 4 and footnote state the shares were withheld or surrendered to satisfy tax withholding obligations from restricted stock vesting. This indicates administrative tax-withholding dispositions rather than discretionary open-market sales initiated for portfolio or liquidity reasons.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 03:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Price Andrew L

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/19/2026		F		3,692(1)	D	$107.15	75,633	D
Encompass Health Common Stock	02/20/2026		F		228(1)	D	$106.55	75,405	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Mr. Price	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.